These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 1069558

  • 1. Immunotherapy of osteosarcoma patients with virus-modified tumor cells.
    Green AA, Pratt C, Webster RG, Smith K.
    Ann N Y Acad Sci; 1976; 277(00):396-411. PubMed ID: 1069558
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Enhancement of antitumor immunity by combining anti-cytotoxic T lymphocyte antigen-4 antibodies and cryotreated tumor lysate-pulsed dendritic cells in murine osteosarcoma.
    Kawano M, Itonaga I, Iwasaki T, Tsumura H.
    Oncol Rep; 2013 Mar; 29(3):1001-6. PubMed ID: 23291864
    [Abstract] [Full Text] [Related]

  • 6. Auto T cells expressing chimeric antigen receptor derived from auto antibody might be a new treatment for osteosarcoma.
    Weibo P, Zhaoming Y.
    Med Hypotheses; 2012 May; 78(5):616-8. PubMed ID: 22330890
    [Abstract] [Full Text] [Related]

  • 7. Editorial: New therapies for osteogenic sarcoma.
    Campbell CJ, Cohen J, Enneking WF.
    J Bone Joint Surg Am; 1975 Mar; 57(2):143-4. PubMed ID: 1054022
    [No Abstract] [Full Text] [Related]

  • 8. Transfer factor therapy in osteogenic sarcoma.
    Levin AS, Byers VS, Fudenberg HH, Wybran J, Hackett AJ, Johnston JO.
    Trans Assoc Am Physicians; 1974 Mar; 87():153-8. PubMed ID: 4549141
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A new antisarcoma strategy: multisubtype heat shock protein/peptide immunotherapy combined with PD-L1 immunological checkpoint inhibitors.
    Li H, Sui X, Wang Z, Fu H, Wang Z, Yuan M, Liu S, Wang G, Guo Q.
    Clin Transl Oncol; 2021 Aug; 23(8):1688-1704. PubMed ID: 33792840
    [Abstract] [Full Text] [Related]

  • 12. Immune approaches to treating osteosarcoma.
    Marina N, Gorlick R.
    Cancer Biol Ther; 2009 May; 8(10):981-3. PubMed ID: 19395866
    [No Abstract] [Full Text] [Related]

  • 13. [Inducing specific antitumor effects on osteosarcoma by fused vaccine of rat dendritic cells].
    Yu Z, Fan QY, Ma BA, Hao XB, Long H.
    Ai Zheng; 2005 Mar; 24(3):285-91. PubMed ID: 15757528
    [Abstract] [Full Text] [Related]

  • 14. Recognition by cellular and humoral autologous immunity in a human osteosarcoma cell line.
    Nabeta Y, Kawaguchi S, Sahara H, Ikeda H, Hirohashi Y, Goroku T, Sato Y, Tsukahara T, Torigoe T, Wada T, Kaya M, Hiraga H, Isu K, Yamawaki S, Ishii S, Yamashita T, Sato N.
    J Orthop Sci; 2003 Mar; 8(4):554-9. PubMed ID: 12898310
    [Abstract] [Full Text] [Related]

  • 15. Immunological studies in murine osteosarcoma. Immunogenicity, growth kinetics, and immunotherapy.
    Miller CW, DeBlasi RF, Fisher SJ.
    J Bone Joint Surg Am; 1976 Apr; 58(3):312-7. PubMed ID: 1063129
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Immune response to sarcomas. A review.
    Weinert CR, McMaster JH, Ferguson RJ.
    Clin Orthop Relat Res; 1974 Apr; (102):207-16. PubMed ID: 4529323
    [No Abstract] [Full Text] [Related]

  • 19. Cellular and humoral influenza-specific immune response upon vaccination in patients with common variable immunodeficiency and unclassified antibody deficiency.
    Hanitsch LG, Löbel M, Mieves JF, Bauer S, Babel N, Schweiger B, Wittke K, Grabowski P, Volk HD, Scheibenbogen C.
    Vaccine; 2016 May 05; 34(21):2417-2423. PubMed ID: 27055021
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.